MedDataX Logo

Incidental Findings on Coronary Computed Tomography Angiography

NCT ID: NCT07275281

Last Updated: 2025-12-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2026-01-02

Study Completion Date

2027-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Coronary CT angiography (CCTA) is increasingly used for ischemic heart disease diagnosis. The rising number of CCTA tests has led to a significant increase in the number of finding unexpected incidental extracardiac diseases.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The increasing utilization of coronary computed tomography (CT) angiography (CCTA) to diagnose and triage patients with suspected or known ischemic heart disease has led to a parallel increase in the frequency of incidental findings in the coronaries (nonatherosclerotic), noncoronary cardiac structures and noncardiac structures.

Studies have reported a prevalence of incidental findings on CCTA up to 40%. Most of these findings have no clinical relevance, but some have significant clinical implications in the care and prognosis of the patients.

We sought to assess the frequency of incidental findings on CCTA scans in consecutive studies performed in the past 5 years.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Computed Tomography Coronary Angiography Incidental Findings

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Coronary artery disease computed tomography indidental findings

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adult patients who underwent CCTA

All adults (18 years of age and older0 who underwent CCTA to evaluate the coronary arteries in the past 5 years will have their CT scans reviewed for the presence of non coronary incidental findings.

CCTA (Review of the scans)

Intervention Type DIAGNOSTIC_TEST

Reviewing coronary scans done in the past 5 years looking for findings other than atherosclerotic coronary artery disease.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CCTA (Review of the scans)

Reviewing coronary scans done in the past 5 years looking for findings other than atherosclerotic coronary artery disease.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients ho underwent CCTA

Exclusion Criteria

* None
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jordan Collaborating Cardiology Group

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Istishari Hospital

Amman, , Jordan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Jordan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Wasfi Alghween, MD

Role: CONTACT

Phone: +96265001000

Email: [email protected]

Musa Saadeh

Role: CONTACT

Phone: 065001000

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ayman Hammoudeh, MD, FACC

Role: primary

Wasfi Alghween, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

JOINCIDENT.CCTA.NOV2025/3

Identifier Type: -

Identifier Source: org_study_id